Skip to main content
Premium Trial:

Request an Annual Quote

Consortium Launches Genomic-Based Clinical Trial for Pediatric Neuroblastoma

Premium

The Neuroblastoma and Medulloblastoma Translational Research Consortium said this week that it has launched a clinical trial that will use genomic analyses to help guide therapy for children with relapsed and refractory neuroblastoma.

The trial, which has been approved by the Food and Drug Administration and will begin enrollment immediately, will use next-generation sequencing and gene expression analysis to provide information about a patient's disease state and to identify targets for therapy.

"We are confident the genomic-based personalized medicine approach, often defined as 'the right treatment for the right patient at the right time,' will provide the necessary data to validate this approach as the new standard of care in the 21st century,” said Giselle Sholler, the chair of the consortium, in a statement.

Based at the Van Andel Research Institute in Grand Rapids, Mich., the NMTRC is a network of 11 pediatric cancer clinical trial sites that includes the National Cancer Institute, universities, and children's hospitals.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.